Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress.
Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress.
复制标题
DOI:
10.1016/j.neuropharm.2022.109233
复制
发表时间:
2022-11-01
影响因子:
4.7
通讯作者:
Ye, Yi
中科院分区:
文献类型:
--
作者:
Zhang, Morgan;Hu, Min;Alles, Sascha R. A.;Montera, Marena A.;Adams, Ian;Santi, Maria D.;Inoue, Kenji;Tu, Nguyen Huu;Westlund, Karin N.;Ye, Yi
Chemotherapy-induced neuropathic pain (CINP) is a debilitating and difficult-to-treat side effect of chemotherapeutic drugs. CINP is marked with oxidative stress and neuronal hypersensitivities. The peroxisome proliferator-activated receptor gamma (PPARγ) is a transcription factor that regulates genes involved in oxidative stress and inflammation. We hypothesize that PPARγ agonists are protective against CIPN by reducing oxidative stress and inhibiting neuronal hypersensitivities. To test our hypothesis, acute or chronic CIPN was introduced by short or long-term treatment of oxaliplatin in BALB/c mice. CIPN mice were treated with either a novel blood-brain barrier (BBB) penetrable PPARγ agonist ELB00824, or a BBB non-penetrable PPARγ agonist pioglitazone, or vehicle. Cold allodynia, mechanical allodynia, motor coordination, sedation and addiction were measured with dry ice, von Frey filaments, beam-walking tests, and conditioned place preference, respectively. Oxidative stress was accessed by measuring byproducts of protein oxidation (carbonyl and 3-Nitrotyrosine) and lipid peroxidation [Thiobarbituric acid reactive substances (TBARS)], as wells as gene expression of Cat, Sod2, Ppargc1a. The effects of ELB00824 on nociceptor excitability were measured using whole-cell electrophysiology of isolated dorsal root ganglion neurons. Preemptive ELB00824, but not pioglitazone, reduced oxaliplatin-induced cold and mechanical allodynia and oxidative stress. ELB0824 suppressed oxaliplatin-induced firing in IB4− neurons. ELB00824 did not cause motor discoordination or sedation/addiction or reduce the antineoplastic activity of oxaliplatin (measured with an MTS-based cell proliferation assay) in a human colon cancer cell line (HCT116) and a human oral cancer cell line (HSC-3). Our results demonstrated that ELB00824 prevents oxaliplatin-induced pain, likely via inhibiting neuronal hypersensitivities and oxidative stress.
登录
查看更多内容
影响因子:
3.9
作者:
G KK;Thaggikuppe Krishnamurthy P;Ammu V V V RK;Vishwanath K;Narenderan ST;Babu B;Krishnaveni N
通讯作者:
Krishnaveni N
影响因子:
4.6
作者:
Chang KL;Pee HN;Yang S;Ho PC
通讯作者:
Ho PC
影响因子:
8.8
作者:
Huang, Zhen-Zhen;Li, Dai;Xin, Wen-Jun
通讯作者:
Xin, Wen-Jun
影响因子:
3.1
作者:
Heppner, TJ;Bonev, AD;Nelson, MT
通讯作者:
Nelson, MT
影响因子:
--
作者:
Jain, Vivek;Jaggi, Amteshwar Singh;Singh, Nirmal
通讯作者:
Singh, Nirmal